-Frederick R Appelbaum Researcher Activity Profile

Research Author Detailed Information 

Frederick R Appelbaum Publication Rate By Year

Frederick R Appelbaum has published 1 paper(s) in 2001, 1 paper(s) in 2002, 6 paper(s) in 2007, 3 paper(s) in 2008, for a total of 11 research publications in total.

Frederick R Fr Appelbaum Author Information

LAST NAME: appelbaum

FIRST NAME: Frederick R

INITIALS: fr

AFFILIATION:

Papers

Frederick R Appelbaum's Publication Record

1. High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma. Year Published: 2007
Department of Medicine, Division of Medical Oncology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98195, USA. agopal@u.washington.edu
2. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington.
3. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Year Published: 2007
4. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington 98109, USA. spetersd@u.washington.edu
5. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington 98109, USA. spetersd@u.washington.edu
6. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Year Published: 2007
Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA 98109-1024, USA. msorror@fhcrc.org
7. Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy. Year Published: 2008
8. Acute myeloid leukemia. Year Published: 2001
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
9. Acute lymphoblastic leukemia. Year Published: 2002
University Hospital, Medizinische Klinik III, Theodor Stern Kai 7, Frankfurt, Germany.
10. Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy. Year Published: 2008
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. jpagel@fhcrc.org
11. Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Year Published: 2008
Division of Hematology and Hematopoietic Cell Transplantation, Department of Cytogenetics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA. vpullarkat@coh.org